Роль чинників росту у розвитку доброякісної гіперплазії передміхурової залози та їх зв'язок із метаболічним синдромом

М. Л. Кирилюк, Ф. І. Костєв, А. В. Підаєв, С. С. Шаталюк

Анотація


Literature review presents current data on the physiological role of growth factors and their involvement in the formation of benign prostatic hyperplasia and metabolic syndrome.


Ключові слова


metabolic syndrome; benign prostatic hyperplasia

Повний текст:

PDF

Посилання


Возіанов О. Ф. Роль факторів росту в патогенезі гіперплазії простати / О. Ф. Возіанов, С. П. Пасічников, А. О. Андреєв // Урологія. – 1999. – № 3. – С. 93-98.

Гладкова А. И. Роль фактора роста в мужской репродукции. Сообщение 1. Инсулиноподобные факторы роста / А. И. Гладкова // Проблемы эндокринной патологии. – 2005. – № 2. – С. 76-86.

Зезеров В. Г., Северин Е. С. Молекулярные механизмы онкогенеза предстательной железы / В. Г. Зезеров, Е. С. Северин // Вестник РАМН. – 1998. – №5. – С. 29-35.

Копнер Р. Б. Инсулиноподобные факторы роста , или соматомедины, - новое семейство пептидных биорегуляторов / Р. Б. Копнер, А. А. Булатов // Успехи современной биологии. – 1984. – Т. 97, №2. – С. 225-240.

Лучицький Є. В. Метаболічний синдром та цукровий діабет 2 типу у чоловіків: роль андронодефіцитного стану / Є. В. Лучицький // Інноваційні технології в сучасній ендокринології: 52 щорічна наук.-практ. конф. з міжнародною участю : зб. лекцій. – Харків, 2008. – С. 67-74.

Переверзев А. С. Аденома предстательной железы / А. С. Переверзев, Н. Ф. Сергиенко. – К.: Ваклер. – C. 277.

Роль тестостерона в регуляции экспрессии генов некоторых факторов пролиферации / А. В. Печерский, О. Б. Лоран, В. И. Печерский [и др.] // Цитология. – 2006. – №48(10). – С. 856-861.

Aaronson N.K. Quality of life: what is it? How should it be measured? / N.K. Aaronson // Oncology. – 1998. – Vol. 2. – P. 69-74.

Alteration in the pulsatile properties of circulating growth hormone concentrations during puberty in boys / P.M. Martha, A. D. Rogol, J. D. Veldhuis [et al.] // The Journal of clinical endocrinology and metabolism. -1989. – Vol. 69, №3. – P. 563-570. https://doi.org/10.1210/jcem-69-3-563

Analysis of serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in benign prostatic hyperplasia / J.P. Yu, X.M. Wu , J.G. Chen [et al.] // Zhonghua Nan Ke Xue. – 2003. – Vol. 9(5). – P. 341-343.

Circulating insulin-like growth factor-I and benign prostatic hyperplasia – a prospective study / P. Stattin, R. Kaaks, E. Riboli [et al.] // Scandinavian journal of urology and nephrology. – 2001. – Vol. 35(2). – P. 122-126. https://doi.org/10.1080/003655901750170506

Cohen P. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues / P. Cohen, S.E. Nunn, D.M. Peehl // The Journal of endocrinology. – 2000. – Vol. 164(2). – P. 215-223. https://doi.org/10.1677/joe.0.1640215

Delsite R. Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: A role in selective neurotrophin stimulation of prostate epithelial cell growth / R. Delsite, D. Djakiew // Prostate. – 1999. – Vol. 41, №1. – P. 39-48. https://doi.org/10.1002/(sici)1097-0045(19990915)41:1<39::aid-pros6>3.0.co;2-e

Differential immunoreactivity of transforming growth factor-alpha in benign, dysplastic and malignant prostatic tissues / C.N. Robertson, K.M. Robertson, A.G. Herberg [et al.] // Surgical oncology. – 1994. – Vol. 3. – P. 234-242. https://doi.org/10.1016/0960-7404(94)90039-6

Differentiation effect of keratinocyte growth factor (KKGF) on aromatase activity in cultured canine prostatic epithelial cell / H. Canatan, F. Shidaifat, S.K. Kulp [et al.] // Endocrine research. – 1997. – Vol. 23, №4. – P. 311-323. https://doi.org/10.1080/07435809709031860

Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? / V.C. Mishra, D.J. Allen, C. Nicolaou [et al.] // BJU. – 2007. – Vol. 100, № 2. – P. 327-331. https://doi.org/10.1111/j.1464-410x.2007.06910.x

Donjacour A.A. FGF-10 plays an essential role in the growth of the fetal prostate / A.A. Donjacour, A.A. Thomson, G.R. Cunha // Developmental biology. – 2003. – Vol. 261, №1. – P. 39-54. https://doi.org/10.1016/s0012-1606(03)00250-1

Expression and effect of insulin-like growth factor I on rat fetal Leydig cell function and differentiation / V. Rouiller, L. Lecerf, C. Gautier [et al.] / / Endocrinology. – 1998. – Vol. 139, №6. – P. 2926-2934. https://doi.org/10.1210/endo.139.6.6035

Garde S.V. Immunopeoxidase localization of prostates inhibin peptide in human, monkey, dog, and rat prostates / S.V. Garde, A.R. Sheth // The Anatomical record. – 1989. – Vol. 223, №2. – P. 181-184. https://doi.org/10.1002/ar.1092230210

Groham C.W. Distribution of nerve growth factorlike protein and nerve growth factor receptor in human prostatic hyperplasia and prostatic adenocarcinoma / C.W. Groham, J.H. Lynch, D. Djaldew // The Journal of urology. – 1992. – Vol. 147. – P. 1444-1447.

Growth hormone directly affects the function of the different lobes of the rat prostate / E. Reiter, O. Kesha, B. Henrruy [et al.] // Endocrinology. – 1995. -Vol. 136, №8. – P. 3338-3345. https://doi.org/10.1210/endo.136.8.7628369

Hormonal modulation of invitro biosynthesis of inhibin like peptide by human prostate. / G.R. Vanage, M.A. Phadke A.H. Bandivdekar [et al.] // Andrologia. – 1990. – Vol. 22, №l. – P. 7-11. https://doi.org/10.1111/j.1439-0272.1990.tb01932.x

Insulin-like growth factor (IGF)-I controls prostate fibromuscular development: IGF-I inhibition prevents both fibromuscular and glandular development in eugonadal mice / D.L. Kleinberg, W. Ruan, D. Yee [et al.] // Endocrinology. – 2007. – Vol. 148(3). – P. 1080-1088. https://doi.org/10.1210/en.2006-1272

Insulin-like growth factors and risk of benign prostatic hyperplasia / A.P. Chokkalingam, Y.T. Gao, J. Deng [et al.] // Prostate. – 2002. – Vol. 52(2). – P. 98-105. https://doi.org/10.1002/pros.10096

Itoh N. Developmental and hormonal regulation of transforming growth factor-? and epidermal growth factor receptor gene expression in insolated prostatic epithelial and stromal cells / N. Itoh, U. Patel, M.K. Skinner // Endocrinology. – 1998. – Vol. 139, №3. – P. 1369-1377. https://doi.org/10.1210/en.139.3.1369

Kharbanda K. Further studies on the synthesis and secretion of inhibin-like material by rat ventral prostate explants in vitro / K. Khrbanda, S. Duraiwami // Prostate. – 1990. – Vol. 16, №2. – P. 163-172. https://doi.org/10.1002/pros.2990160207

Localization of epidermal growth factor receptors in human prostate by biochemical and immunocytochemical methods / S.Q. Maddy, G.D. Chisholm, R.A. Hawkins [et al.] // The Journal of endocrinology. – 1987. – Vol. 113. – P. 147-153. https://doi.org/10.1677/joe.0.1130147

Matsuda T. Relation between benign prostatic hyperplasia and obesity and estrogen / T. Matsuda, H. Abe, K. Suda // Rinsho byori. – 2004. – Vol. 52, №4. – P. 291-294.

Monti S. Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgen / S. Monti, F. Di Silverio, S. Lanzara // Steroids. – 1998. – Vol. 63(5-6). – P. 362-366. https://doi.org/10.1016/s0039-128x(98)00034-8

Nickerson T. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4 and 5 / T. Nickerson, M. Pollak, H. Huynh // Endocrinology. – 1998. – Vol. 139, №2. – P. 807-810. https://doi.org/10.1210/endo.139.2.5912

Opposing actions of TGF-beta-1 and FGF-2 on growth, differentiation and extracellular matrix accumulation in prostatic stromal cells / N.A. Cross, S.V. Reid, A.J. Harvey [et al.] // Growth Factors. – 2006. – Vol. 24(4). – P. 233-41. https://doi.org/10.1080/08977190600976501

Paracrine regulation of testicular function: growth factors as paracrine regulation of testicular function / J.M. Saez, O. Avallet, M. Vigier [et al.] // 31 Int. Congr. Physiol. Sci, Helsinki. – Oulu, 1989. – P. 17-19.

Pollan M.C. Growth factor expression in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens / M.C. Pollan, H.A. Benghuzzi, M. Tucci // Biomedical sciences instrumentation. – 2003. – Vol. 39. – P. 329-334.

Profiling molecular targets of TGF-beta1 in prostate fibroblast – to myofibroblast transdifferentiation / G. Untergasser, R. Gander, C. Lilg [et al.] // Mechanisms of ageing and development. – 2005. – Vol. 126(1). – P. 59-69. https://doi.org/10.1016/j.mad.2004.09.023

Regional expression of transforming growth factor-alpha in rat ventral prostate during postnatal development, after androgen ablation, and after androgen replacement / S. Banerjee, P.P. Banerjee, R.B. Zirtkin [et al.] // Endocrinology. – 1998. – Vol. 155, №6. – P. 3005-3013. https://doi.org/10.1210/endo.139.6.6060

Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens / S. Monti, F. Di Silverio, R. Iraci [et al.] // The Journal of clinical endocrinology and metabolism. – 2001. – Vol. 86(4). – P. 1700-1706. https://doi.org/10.1210/jcem.86.4.7413

Story M.T. Positive and negative modulators of prostate cell proliferations / M.T. Story // Biomedicine & pharmacotherapy. – 1994. – Vol. 48, № 1. – P. 359-415. https://doi.org/10.1016/s0753-3322(09)80007-3

Transforming growth factor-β induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells / M.L. Gerdes, T.D. Dang, M. Larsen [et al.] // Endocrinology. – 1998. – Vol. 139, № 8. – P. 5369-5377. https://doi.org/10.1210/en.139.8.3569

Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cell exposed to high concentrations of estradiol / P. Smith, N.P. Rhodes, Y. Ke [et al.] // Prostate cancer and prostatic diseases. – 2002. – Vol. 5, №2. – P. 105-110. https://doi.org/10.1038/sj.pcan.4500571

Zhang Hong. Insulin-like growth factor 1 – mediated degradation of insulin receptor substrate I is inhibited by epidermal growth factor in prostate epithelial cells / Zhang Hong // The Journal of biological chemistry. – 2000. -Vol. 275, №29. – P. 22558-22562. https://doi.org/10.1074/jbc.m000412200


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24026/1818-1384.3(40).2012.83187



Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія.

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter